https://www.selleckchem.com/products/smi-4a.html
also exceeded the MCID. PROM scores in patients with hip osteoarthritis varied among those with different insurance types. Variations in certain demographic and health indices are potential drivers of these observed baseline PROM differences. For patients with hip osteoarthritis, the use of PROMs for research, clinical, or quality-linked payment metrics should acknowledge baseline variation between patients with different insurance types. Prognostic Level IV. See Instructions for Authors for a complete description of levels of evidence.
Like
Comment
Share
